发明名称 HETEROCYCLIC DIHYDROPYRIMIDINE COMPOUNDS
摘要 FIELD: organic chemistry, heterocyclic compounds, medicine. ^ SUBSTANCE: invention relates to dihydropyrimidine compounds of the formula (I*): their enantiomers, diastereoisomers and pharmaceutically acceptable salts wherein X1, X2 and X3 in common with atoms to which they are added form ring of the formula: or ; R1 represents hydrogen atom; R2, R3*, R4, R5, R6 and R7 have values given in cl. 1 of the invention claim. Also, invention relates to separate dihydropyrimidine compounds. Proposed compounds are inhibitors of calcium channel function being especially inhibitors of Kv1 subfamily of potential-overlapping K+-channels and especially inhibitors of Kv 1.5 that associated with super-rapid activating delayed cleaning K+-flow of Ikur and can be used in treatment of arrhythmia and Ikur-associated diseases. ^ EFFECT: valuable medicinal properties of compounds. ^ 15 cl, 589 ex
申请公布号 RU2296766(C2) 申请公布日期 2007.04.10
申请号 RU20020118622 申请日期 2000.12.04
申请人 BRISTOL-MAERS SKVIBB KOMPANI 发明人 EHTUOL KARNEHJL S.;VAKKARO UEHJN;LLOJD DZHON;FINLEJ KHIZER;JAN LIN S.;BKHANDARU RAO
分类号 C07D487/04;A61K31/519;A61K31/55;A61K45/00;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P3/06;A61P3/10;A61P5/14;A61P7/02;A61P7/06;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P17/08;A61P17/14;A61P19/02;A61P19/10;A61P21/00;A61P21/04;A61P25/06;A61P25/08;A61P25/16;A61P25/28;A61P27/02;A61P27/12;A61P27/16;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P31/22;A61P35/00;A61P35/02;A61P35/04;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D519/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址